Clinical Trials Directory

Trials / Completed

CompletedNCT05699707

Metabolomic Signature of Exogenous Ketosis

The Effect of Acute Exogenous Oral Ketone Supplementation on the Plasma Metabolomic Signature in Healthy Individuals: An Exploration of Novel Ketone-derived Metabolites

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
5 (actual)
Sponsor
University of British Columbia · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Ketone bodies are a fuel source and signaling molecule that are produced by your body during prolonged fasting or if you consistently eat at low-carbohydrate diet. Blood ketones can be used as a source of energy during fasting and are used by your brain as an alternative source of fuel to glucose. Previous studies have found that ketones, when consumed in form of a supplement drink, can increase blood ketone levels and lower blood glucose, the amount of sugar in your blood. This is of potential interest for individuals with high blood sugar, such as people living with type 2 diabetes. However, how ketone supplements impact metabolism is not fully understood but using high throughput analysis techniques that can characterize hundreds to thousands of metabolites in the blood (known as "metabolomics") may allow researchers to discover novel compounds within the body that are altered by ketone supplements. This will improve our understanding of how ketones impact metabolism and guide future research.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENT(R)-3-hydroxybutyl (R)-3-hydroxybutyrate ketone monoesterParticipants will consume a ketone monoester drink (0.75 k/kg body mass) with venous blood samples obtained before and after (30, 60 and 90 minutes) drink consumption.

Timeline

Start date
2023-02-01
Primary completion
2023-04-01
Completion
2023-04-01
First posted
2023-01-26
Last updated
2023-05-16

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05699707. Inclusion in this directory is not an endorsement.

Metabolomic Signature of Exogenous Ketosis (NCT05699707) · Clinical Trials Directory